Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6012179 | Epilepsy & Behavior | 2014 | 5 Pages |
Abstract
Results emphasize that, in clinical practice, approximately half of GCSE patients respond to first-line therapy and, among nonresponders, approximately two-thirds respond to second-line and approximately three-quarters respond to third-line therapies. The variations in treatment selection reflect that there are no randomized controlled trials to guide treatment beyond use of benzodiazepines for first-line treatment. The observation that phenytoin is statistically substantially worse than other second-line treatments raises the possibility that the most commonly selected second-line treatment is the least effective and provides equipoise for a large randomized controlled trial of second-line therapies.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Jennifer E. Langer, Nathan B. Fountain,